The abstract is read at the publisher; the summary is JClub's.
SIRT3 deficiency suppresses colorectal cancer progression by inducing mitochondrial dysfunction-associated senescence (MIDAS), linked to SLC25A13 hyperacetylation at lysine 568.
- Why it matters: The mechanism connecting SIRT3 to MIDAS and how MIDAS influences colorectal cancer progression is not fully understood, limiting therapeutic targeting.
- What they did: The study shows SIRT3 deacetylates SLC25A13 at lysine 568; loss of SIRT3 increases K568 acetylation, disrupts the malate-aspartate shuttle, lowers cytosolic NAD+/NADH, and activates the AMPK–p53 axis to trigger MIDAS.
- The result: Low SLC25A13-K568 acetylation associates with poor prognosis in human CRC, and senolytic treatment selectively removes these senescent cells and suppresses tumor growth.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.